Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
FRAZIER LIFESCIENCES ACQUISITION CORPORATION | NAMS | Nasdaq +4 Other | 120,126 | 19.81 EUR | Stock | |
NEWAMSTERDAM PHARMA COMPANY N.V. | NAMS | Nasdaq | 111,764 | 19.81 USD | ||
NEWAMSTERDAM PHARMA COMPANY N.V. | KH6 | Deutsche Boerse AG | - | 17.9 EUR | ||
NEWAMSTERDAM PHARMA COMPANY N.V. | KH6 | Börse Stuttgart | - | 17.8 EUR | ||
NEWAMSTERDAM PHARMA COMPANY N.V. | KH6 | BOERSE MUENCHEN | - | 18.3 EUR | ||
INCH KENNETH KAJANG RUBBER PUBLIC LIMITED COMPANY | INCKEN | BURSA MALAYSIA +1 Other | 27,920 | 0.405 MYR | Stock | |
INCH KENNETH KAJANG RUBBER PUBLIC LIMITED COMPANY | I4R | Singapore S.E. | - | - SGD |
News (426)
Companies (2)
Titan Company Limited specializes in the design, manufacture and marketing of watches, jewellery, eyewear and fashion accessories. Net sales break down by product family as follows: - jewellery items (88.5%): gold jewellery decorated with diamonds and pr ...
Inch Kenneth Kajang Rubber Public Limited Company is an investment holding company and carries on the business of an oil palm grower in Selangor, Malaysia. The Company, through its subsidiary, is engaged in the operations of a block rubber manufacturer, t ...
Insiders
Kenneth Carleton Frazier (born ) is an American business executive. He is the Chairman and CEO of the pharmaceutical company Merck & Co. After joining Merck as general counsel, he directed the company's defense against litigation over the anti-inflammatory drug Vioxx. Frazier is the first African-American to lead a major pharmaceutical company.
Early life
Kenneth Frazier was born on December 17, 1954, in North Philadelphia.
Source @ Wikipedia
Mr. Branden R.
Frazier is a Managing Director & Partner at Creative Planning LLC.
He is also a member of the firm’s Investment Committee.
He received his undergraduate degree from the University of California, Irvine and an MBA from the University of California, Irvine.
Kenny S.
Frazier held the position of Senior Director-Clinical Operations at Lexicon Pharmaceuticals, Inc. and the position of VP-Clinical Development & Regulatory Affairs at Opexa Therapeutics, Inc. He obtained an undergraduate degree from Texas Tech University.
Evan Frazier is currently the President & Chief Executive Officer at Advanced Leadership Institute, President & Chief Executive Officer at The Advanced Leadership Institute, Inc., Director-Institute of Physics at the University of Pittsburgh, Director at Phipps Conservatory & Botanical Gardens, Director at The Pittsburgh Foundation, Director at The Andy Warhol Museum, Director at Hill House Economic Development Corp., Trustee at Carnegie Mellon University, Trustee at Carnegie Museums of Pittsburgh, and Principal at The Highmark Foundation.
Previously, he worked as the President & Chief Executive Officer at Hill House Association, Director at The Andy Warhol Museum, Vice President-Strategic Planning at The PNC Financial Services Group, Inc., and Senior Vice President at Manchester Bidwell Corp.
No results for this search
- Stock Market
- Advanced search
- Kenneth Frazier